Thermodynamic investigations of nitroxoline sublimation by simultaneous DSC-FTIR method and isothermal TG analysis

Journal of Pharmaceutical Sciences

Volumn 99, Issue 1, 2010, Pages 255-261

  Gao, Gau Yi ^a   Lin, Shan Yang ^a  

^a YUANPEI UNIVERSITY   (Taiwan)

Author keywords

DSC; DSC FTIR; Nitroxoline; Sublimation; TG; Thermodynamics

Indexed keywords

NITROXOLINE;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STRUCTURE; ENTHALPY; INFRARED SPECTROSCOPY; MELTING POINT; PHYSICAL CHEMISTRY; THERMODYNAMICS; THERMOGRAVIMETRY;

EID: 73949089721     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21826     Document Type: Article

References (29)

1. Medić-Sarić M, Maysinger D, Movrin M, Dvorzak I, Medić-Sarić M, Maysinger D, Movrin M, Dvorzak I. 1980. Antibacterial and antifungal activities of nitroxoline Mannich bases. Chemotherapy 26:263-267.
2. Hernández Molina JM, Llosá J, Ventosa A. 1991. In vitro activity of nitroxoline against clinical isolates of Candida species. Mycoses 34:323-325.
3. Miller LG, Tang AW. 2004. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc 79:1048-1054.
4. Murugasu-Oei B, Dick T. 2001. In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG. Int J Antimicrob Agents 18:579-582.
5. Pelletier C, Prognon P, Bourlioux P. 1995. Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains. Antimicrob Agents Chemother 39:707-713.
6. Abu-Elteen KH, Hamad M. 2005. Antifungal agents for use in human therapy. In: Kavanagh K, editor. Fungi: Biology and applications. New York: John Wiley & Sons, Ltd. pp. 191-217.
7. Ribeiro da Silva MAV, Matos MAR, Amaral LMPF. 1997. Enthalpies of combustion, vapour pressures, and enthalpies of sublimation of 5-, 6-, and 8-nitroquinoline and 8-nitroquinaldine. J Chem Thermodyn 29:295-303.
8. McEachern DM, Iniguez JC, Ornelas HC. 1975. Enthalpies of combustion and sublimation and vapor pressures of three benzoquinolines. J Chem Eng Data 20:226-228.
9. Crespi M, Zorel H, Ribeiro C. 2003. Thermal behavior of the Ti(IV), Zr(IV) and Pb(II) Complexes with 5-Nitro-8-Hydroxyquinoline. J Ther Anal Calorim 72:507-514.
10. Ribeiro da Silva MAV, Monte MJS, Matos MAR. 1989. Enthalpies of combustion, vapour pressures, and enthalpies of sublimation of 8-hydroxyquinoline, 5-nitro-8-hydroxyquinoline, and 2-méthyl-8- hydroxyquinoline. J Chem Thermodyn 21:159-166.
11. Crespi M, Zorel H, Ribeiro C, Costalonga AGC, Torres C. 2001. Sublimation/volatilisation kinetics of 8-hydroxyquinolines and their nitro-derivatives. J Ther Anal Calorim 64:783-787.
12. Cheng WT, Lin SY. 2008. Famotidine polymorphic transformation in the grinding process significantly depends on environmental humidity or water content. Int J Pharm 357:164-168.
13. Wang SL, Lin SY, Hsieh TF, Chan SA. 2007. Thermal behavior and thermal decarboxylation of 10-hydroxycamptothecin in the solid state. J Pharm Biomed Anal 43:457-463.
14. Hsu CH, Lin SY. 2009. Rapid examination of the kinetic process of intramolecular lactamization of gabapentin using DSC-FTIR. Thermochim Acta 486:5-10.
15. Wright SF, Phang P, Dollimore D, Alexander KS. 2002. An overview of calibration material used in thermal analysis - Benzoic acid. Thermochim Acta 1392:251-257.
16. Cox JD, Pilcher G. 1970. Thermochemistry of organic and organometallic compounds. London: Academic Press.
17. De Kruif CG, Blok JG. 1982. The vapour pressure of benzoic acid. J Chem Thermodyn 14:201-206.
18. Price DM, Bashir S, Derrick PR. 1999. Sublimation properties of x,y-dihydroxybenzoic acid isomers as model matrix assisted laser desorption ionisation (MALDI) matrices. Thermochim Acta 327:167-171.
19. Pretsch E, Clerc T, Seibel J, Simon W. 1989. Tables of spectral data for structure determination of organic compounds. 2nd edition. Berlin: Springer-Verlag.
20. Yatsenko AV, Paseshnichenko KA, Chernyshev VV, Schenk H. 2002. Powder diffraction study of the hydrogen bonds in nitroxoline and its hydrochloride. Acta Cryst C58:o19-o21.
21. Xie M, Ziemba TM, Maurin MB. 2003. Sublimation characterization and vapor pressure estimation of an HIV nonnucleoside reverse transcriptase inhibitor using thermogravimetric analysis. AAPS PharmSciTech 4:E23.
22. Krongauz VV, Ling MTK, Woo L, Purohit U. 2007. Kinetics of dihydro-dibenz[b,f]azepine derivatives sublimation. Thermochim Acta 457: 35-40.
23. Gavezzotti A, Filippini G. 1994. Geometry of the intermolecular X-H..Y (X,Y=N,O) hydrogen bond, and the calibration of empirical hydrogen-bond parameters. J Phys Chem 98:4831-4837.
24. Chickos JS, Nichols G, Wilson J, Orf J, Webb P, Wang J. 1999. A Protocol for deriving values for fusion enthalpies (298 K) and vaporization enthalpies (298 K). Applications in obtaining sublimation enthalpies (298 K) in energetics of stable molecules and reactive intermediates. In: Minas da Piedade ME, editor. NATO Science Series C, Vol. 535. Boston: Kluwer Academic Publishers. pp. 177-202.
25. Chickos JS, Acree WE, Jr. 2002. Enthalpies of sublimation of organic and organometallic compounds. 1910-2001. J Phys Chem Ref Data 31:537-698.
26. Chickos JS, Hosseini S, Hesse DG, Liebman JF. 1993. Heat capacity corrections to a standard state: A comparison of new and some literature methods for organic liquids and solids. Struct Chem 4:271-278.
27. Chickos JS, Hesse DG, Liebman JF. 1993. A group additivity approach for the estimation of heat capacities of organic liquids and solids at 298 K. Struct Chem 4:261-269.
28. Perlovich GL, Volkova TV, Bauer-Brandl A. 2006. Towards an understanding of the molecular mechanism of solvation of drug molecules: A thermodynamic approach by crystal lattice energy, sublimation, and solubility exemplified by paracetamol, acetanilide, and phenacetin. J Pharm Sci 95:2158-2169.
29. Ribeiro da Silva MAV, Monte MJS, Matos MAR, Amaral LMPF. 1997. Enthalpies of combustion, vapour pressures, and enthalpies of sublimation of 5-, 6-, and 8-nitroquinoline, and 8-nitroquinqldine. J Chem Thermodyn 29:295-303.